News

CSCI’s first Trainee Day kicks off SCI-TIF’s 2024 events programme

8 February 2024

This Tuesday (6 February), our Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) and Institute researchers participated in our first SCI-TIF event of 2024, highlighting collaboration between industry and academia. The event started with an introduction from CSCI Director Bertie Gottgens, then...

Professor Vassiliou to spearhead £4m project to develop clinical platform for blood cancer prevention with Blood Cancer UK and Leukemia & Lymphoma Society in the US

5 February 2024

On World Cancer Day yesterday (4 February), Blood Cancer UK and the American charity Leukemia & Lymphoma Society (LLS) announced the start of a transformative five-year, £4 million research project in Cambridge, spearheaded by CSCI’s Professor George Vassiliou. The project aims to establish a clinical platform to...

Role of inherited genetic variants in rare blood cancer uncovered by CSCI researchers and collaborators

17 January 2024

Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer. Researchers from the Wellcome-MRC Cambridge Stem Cell Institute, Wellcome Sanger Institute, the University of Cambridge, and collaborators...

Göttgens Group publishes research on a new model

8 January 2024

A new collaborative paper from the Göttgens , Kranc and O’Carroll groups reports the first model of homeostatic in vivo tissue dynamics that is anchored in single cell genomics data in the Cell Stem Cell publication out last week (5 January). In time series measurements extending over 9 months, the Kranc Group (Institute...

PI Kostas Tzelepis presents at the 65th Annual ASH Conference on STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor

12 December 2023

On Friday 8 December, CSCI PI Kostantinos Tzelepis presented his research at the Annual American Society of Hematology (ASH) Meeting in San Diego, USA. This presentation focused on the pre-clinical development and characterisation of the first-in-class METTL1 RNA Methyltransferase inhibitor, a totally novel anticancer...

CSCI celebrates second annual Christmas Market

11 December 2023

On Friday 1 December, CSCI celebrated our second annual Christmas Market at the Jeffrey Cheah Biomedical Centre . Partnering with our neighbours at Cancer Research UK Cambridge Institute and Cambridge Biomedical Campus , and with volunteers from The Milner Therapeutics Institute and Cambridge Institute of Therapeutic...

Dr Alecia-Jane Twigger looking through microscope

Dr Alecia-Jane Twigger wins major Fellowship award to establish a Cambridge lactation lab

4 December 2023

It was announced today that Dr Alecia-Jane Twigger has been awarded a UK Research and Innovation (UKRI) Future Leaders Fellowship. These Fellowships are awarded by UKRI to support universities and businesses in developing their most talented early career researchers and innovators. Dr Twigger, a Research Associate in...

Dr Konstantinos Tzelepis named as an Emerging Leader in Leukaemia

25 October 2023

Last week, the journal Leukemia announced CSCI PI Dr Konstantinos Tzelepis as one of three Emerging Leaders in Leukemia. The Nature Publishing Group journal’s Emerging Leaders collection selects rising talent in the field of haematology, providing a spotlight so they can share their work with others. Kostas and his group...

Sarah Teichmann elected as Professor in Stem Cell Medicine

18 October 2023

It was announced today (18 October) that Dr Sarah Teichmann and her group will join the Cambridge Stem Cell Institute (CSCI) Sarah will be moving from the Wellcome Sanger Institute , where she has been heading the Cellular Genetics programme. Sarah is a highly distinguished computational biologist, and co-lead of the...

CSCI Welcomes Dr Thorsten Boroviak as new Group Leader

10 October 2023

Dr Thorsten Boroviak joins us this month (from 1 October) as a Principal Investigator researching primate embryogenesis. Dr Boroviak joins us from the Department of Physiology, Development and Neuroscience at University of Cambridge. CSCI Director Bertie Göttgens comments on Dr Boroviak's appointment: "I am very happy to...